Tag Archives: Infants

CDC analysis of data from US territories finds serious birth defects in about 1 in 12 fetuses or infants of pregnant women with Zika infection in the first trimester – Press Release

In the U.S. territories, 5 percent of women who had confirmed Zika virus infection during pregnancy had a baby or fetus with Zika virus-associated birth defects

Some Infants still not receiving the recommended screenings and interventions for hearing loss and critical congenital heart disease at birth – Press Release

About 1 in 500 infants are born with CCHD, which includes the more severe forms of congenital heart disease (CHD).

Forum on the Diagnosis, Evaluation, and Management of Zika Virus Infection among Infants – Media Advisory

This Forum will be an opportunity to convene experts to review emerging evidence and collect individual expert input regarding the diagnosis, evaluation and management of infants with possible congenital Zika virus infection.

CDC updates guidance for infants born to mothers with possible Zika virus infection during pregnancy – Press Release

This update includes information that has become available since the August 2016 release of the previous guidance.

CDC and FDA Expedite the Availability of Additional Doses of New RSV Immunization for Infants

Today, CDC announced the release of more than 77,000 additional doses of Beyfortus(TM) (nirsevimab-alip (100 mg), a long-acting monoclonal antibody designed to protect infants against severe respiratory syncytial virus (RSV) disease. 

CDC Recommends a Powerful New Tool to Protect Infants from Leading Cause of Hospitalization

CDC is recommending a new immunization starting this fall to help protect all infants under 8 months and some older babies at increased risk of severe illness caused by respiratory syncytial virus (RSV).

Whooping cough vaccination during pregnancy benefits US infants

A CDC study published today provides further evidence that Tdap vaccination during pregnancy helps protect newborns from whooping cough during their first two months of life, when they are most vulnerable to the disease.